| Year |
Citation |
Score |
| 2024 |
Yamada-Hunter SA, Theruvath J, McIntosh BJ, Freitas KA, Lin F, Radosevich MT, Leruste A, Dhingra S, Martinez-Velez N, Xu P, Huang J, Delaidelli A, Desai MH, Good Z, Polak R, ... ... Banuelos A, et al. Engineered CD47 protects T cells for enhanced antitumour immunity. Nature. PMID 38750365 DOI: 10.1038/s41586-024-07443-8 |
0.657 |
|
| 2024 |
Banuelos A, Zhang A, Berouti H, Baez M, Yılmaz L, Georgeos N, Marjon KD, Miyanishi M, Weissman IL. CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance. Proceedings of the National Academy of Sciences of the United States of America. 121: e2318534121. PMID 38261615 DOI: 10.1073/pnas.2318534121 |
0.648 |
|
| 2022 |
Theruvath J, Menard M, Smith BAH, Linde MH, Coles GL, Dalton GN, Wu W, Kiru L, Delaidelli A, Sotillo E, Silberstein JL, Geraghty AC, Banuelos A, Radosevich MT, Dhingra S, et al. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nature Medicine. PMID 35027753 DOI: 10.1038/s41591-021-01625-x |
0.672 |
|
| 2021 |
Kamber RA, Nishiga Y, Morton B, Banuelos AM, Barkal AA, Vences-Catalán F, Gu M, Fernandez D, Seoane JA, Yao D, Liu K, Lin S, Spees K, Curtis C, Jerby-Arnon L, et al. Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis. Nature. PMID 34497417 DOI: 10.1038/s41586-021-03879-4 |
0.407 |
|
| 2021 |
Upton R, Banuelos A, Feng D, Biswas T, Kao K, McKenna K, Willingham S, Ho PY, Rosental B, Tal MC, Raveh T, Volkmer JP, Pegram MD, Weissman IL. Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34257155 DOI: 10.1073/pnas.2026849118 |
0.402 |
|
| 2021 |
Li J, Brickler T, Banuelos A, Marjon K, Shcherbina A, Banerjee S, Bian J, Narayanan C, Weissman IL, Chetty S. Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33833053 DOI: 10.1073/pnas.2005483118 |
0.627 |
|
| 2020 |
Theruvath J, Smith B, Linde MH, Sotillo E, Heitzeneder S, Marjon K, Tousley A, Lattin J, Banuelos A, Dhingra S, Murty S, Mackall CL, Majzner RG. Abstract PR07: GD2 is a macrophage checkpoint molecule and combined GD2/CD47 blockade results in synergistic effects and tumor clearance in xenograft models of neuroblastoma and osteosarcoma Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-Pr07 |
0.647 |
|
| 2018 |
Feng M, Marjon KD, Zhu F, Weissman-Tsukamoto R, Levett A, Sullivan K, Kao KS, Markovic M, Bump PA, Jackson HM, Choi TS, Chen J, Banuelos AM, Liu J, Gip P, et al. Programmed cell removal by calreticulin in tissue homeostasis and cancer. Nature Communications. 9: 3194. PMID 30097573 DOI: 10.1038/S41467-018-05211-7 |
0.608 |
|
| Show low-probability matches. |